Share on StockTwits

athenahealth (NASDAQ:ATHN) CEO Jonathan Bush sold 1,000 shares of the stock on the open market in a transaction dated Monday, August 4th. The stock was sold at an average price of $121.58, for a total value of $121,580.00. Following the completion of the transaction, the chief executive officer now directly owns 311,234 shares of the company’s stock, valued at approximately $37,839,830. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Shares of athenahealth (NASDAQ:ATHN) traded up 0.93% during mid-day trading on Tuesday, hitting $124.81. 371,512 shares of the company’s stock traded hands. athenahealth has a 52-week low of $97.30 and a 52-week high of $206.70. The stock has a 50-day moving average of $127.8 and a 200-day moving average of $144.3. The company has a market cap of $4.738 billion and a P/E ratio of 1134.50.

athenahealth (NASDAQ:ATHN) last issued its quarterly earnings data on Thursday, July 17th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $0.10. The company had revenue of $185.90 million for the quarter, compared to the consensus estimate of $182.14 million. During the same quarter in the previous year, the company posted ($0.08) earnings per share. The company’s revenue for the quarter was up 27.1% on a year-over-year basis. On average, analysts predict that athenahealth will post $1.09 earnings per share for the current fiscal year.

A number of analysts have recently weighed in on ATHN shares. Analysts at Barclays reiterated an “equal weight” rating on shares of athenahealth in a research note on Monday, July 21st. They now have a $128.00 price target on the stock, up previously from $125.00. Separately, analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of athenahealth in a research note on Monday, July 21st. They now have a $170.00 price target on the stock, down previously from $185.00. Finally, analysts at Citigroup Inc. reiterated a “buy” rating on shares of athenahealth in a research note on Monday, July 21st. They now have a $180.00 price target on the stock, down previously from $200.00. One investment analyst has rated the stock with a sell rating, twelve have given a hold rating and thirteen have given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $163.38.

athenahealth, Inc (NASDAQ:ATHN), is a business services company, which provides ongoing billing, clinical-related, and other related services to its customers.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.